MODEL 302-20 VNS THERAPY LEAD, EXPIR DATE 2/28/05,
Report
- Report Number
- 1644487-2004-00167
- Event Type
- Death
- Date Received
- March 6, 2004
- Date of Event
- February 4, 2004
- Report Date
- February 5, 2004
- Manufacturer
- CYBERONICS, INC.
- Product Code
- LYJ
- PMA / PMN Number
- P970003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SD, US
- Reporter Occupation
- NURSE
Narratives
CAUSE OF DEATH INFORMATION OBTAINED FROM THE NATIONAL DEATH INDEX (NDI) WAS REVIEWED BY THE MANUFACTURER WHICH INDICATED THAT THE PATIENT PASSED AWAY ON (B)(6) 2004 AND THE PATIENT¿S CAUSE OF DEATH WAS POTENTIAL SUDEP, WITH EPILEPSY, UNSPECIFIED, SEQUELAE OF INTRACRANIAL INJURY, AND SEQUELAE OF OTHER ACCIDENTS. A SUDEP (SUDDEN UNEXPECTED DEATH IN EPILEPSY) EVALUATION WAS PERFORMED WHICH DETERMINED THAT THE DEATH MET CRITERIA FOR CLASSIFICATION OF DEFINITE SUDEP. THERE IS NO ALLEGATION OR OTHER INFORMATION INDICATING THAT THE DEATH IS RELATED TO VNS.
CAUSE OF DEATH INFORMATION OBTAINED FROM THE NATIONAL DEATH INDEX (NDI) WAS REVIEWED BY THE MANUFACTURER WHICH INDICATED THAT THE PATIENT PASSED AWAY ON (B)(6) 2004 AND THE PATIENT¿S CAUSE OF DEATH WAS POTENTIAL SUDEP, WITH EPILEPSY, UNSPECIFIED, SEQUELAE OF INTRACRANIAL INJURY, AND SEQUELAE OF OTHER ACCIDENTS. A SUDEP (SUDDEN UNEXPECTED DEATH IN EPILEPSY) EVALUATION WAS PERFORMED WHICH DETERMINED THAT THE DEATH MET CRITERIA FOR CLASSIFICATION OF DEFINITE SUDEP. THERE IS NO ALLEGATION OR OTHER INFORMATION INDICATING THAT THE DEATH IS RELATED TO VNS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MODEL 302-20 VNS THERAPY LEAD, EXPIR DATE 2/28/05, | LYJ | CYBERONICS, INC. | 102 | 7811 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Death | MODEL 302-20 VNS THERAPY LEAD, EXPIR DATE 2/28/05,| MEDICATIONS AT TIME OF DEATH INCLUDE: VALPROATE /| VALPROIC ACID, PHENYTOIN, GABAPENTIN.| DATE OF MFG 2/24/2003, STERILIZATION LOT NO. 7910. |